Login to Your Account



Other news to note


Wednesday, May 16, 2018

Iliad Biotechnologies LLC, of Weston, Fla., and Vanderbilt University Medical Center report that an investigational new drug (IND) application has been filed by the National Institute for Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) to study the next generation pertussis vaccine BPZE1. 

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription